Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 0.00 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Glorywin Entertainment Group Inc (PK) | GWIN | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.0% | 0.1621 | 07:38:13 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.1621 | 0.1621 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0.00 | - | 0.0455 - 0.1621 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.1621 | USD |
Glorywin Entertainment Group Inc (PK) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 57.74M | 356.19M | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Glorywin Entertainment (PK) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GWIN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.1621 | 0.1621 | 0.1621 | 0.1621 | 150 | 0.00 | 0.0% |
| 1 Month | 0.1621 | 0.1621 | 0.1621 | 0.1621 | 150 | 0.00 | 0.0% |
| 3 Months | 0.1112 | 0.1621 | 0.1112 | 0.1318351 | 185 | 0.0509 | 45.77% |
| 6 Months | 0.1112 | 0.1621 | 0.1112 | 0.1318351 | 185 | 0.0509 | 45.77% |
| 1 Year | 0.0455 | 0.1621 | 0.0455 | 0.0718926 | 296 | 0.1166 | 256.26% |
| 3 Years | 0.10 | 0.519 | 0.0121 | 0.168206 | 343 | 0.0621 | 62.1% |
| 5 Years | 1.00 | 1.00 | 0.01 | 0.2888289 | 382 | -0.8379 | -83.79% |
Glorywin Entertainment (PK) Description
| Reska Biotech, Inc. is a 3D bioprinting technology research and development, anti-cancer drug research and development. |
